16.99
price down icon0.82%   -0.14
pre-market  Pre-market:  17.01   0.02   +0.12%
loading
Pulse Biosciences Inc stock is traded at $16.99, with a volume of 90,247. It is down -0.82% in the last 24 hours and down -20.64% over the past month. Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.
See More
Previous Close:
$17.13
Open:
$17.27
24h Volume:
90,247
Relative Volume:
0.58
Market Cap:
$1.04B
Revenue:
-
Net Income/Loss:
$-46.13M
P/E Ratio:
-20.92
EPS:
-0.8123
Net Cash Flow:
$-34.10M
1W Performance:
+0.41%
1M Performance:
-20.64%
6M Performance:
-8.21%
1Y Performance:
+58.19%
1-Day Range:
Value
$16.87
$17.89
1-Week Range:
Value
$16.48
$17.91
52-Week Range:
Value
$6.595
$25.00

Pulse Biosciences Inc Stock (PLSE) Company Profile

Name
Name
Pulse Biosciences Inc
Name
Phone
510-906-4600
Name
Address
3957 POINT EDEN WAY, HAYWARD, CA
Name
Employee
56
Name
Twitter
@PulseBioNPS
Name
Next Earnings Date
2024-10-30
Name
Latest SEC Filings
Name
PLSE's Discussions on Twitter

Compare PLSE with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Instruments & Supplies icon
PLSE
Pulse Biosciences Inc
16.99 1.04B 0 -46.13M -34.10M -0.8123
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
476.78 170.05B 8.35B 2.32B 1.30B 6.41
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
222.79 63.97B 20.64B 1.73B 2.94B 6.02
Medical Instruments & Supplies icon
ALC
Alcon Inc
86.81 42.94B 9.91B 1.02B 665.00M 2.05
Medical Instruments & Supplies icon
RMD
Resmed Inc
219.72 32.28B 4.93B 1.25B 1.38B 8.47
Medical Instruments & Supplies icon
BAX
Baxter International Inc
34.55 17.64B 17.28B 108.00M 391.00M 0.20

Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-27-21 Initiated Stephens Overweight
Mar-11-21 Initiated Maxim Group Buy
Jan-26-21 Reiterated H.C. Wainwright Buy
May-12-20 Upgrade H.C. Wainwright Neutral → Buy
Feb-14-20 Downgrade H.C. Wainwright Buy → Neutral
Feb-25-19 Initiated H.C. Wainwright Buy
View All

Pulse Biosciences Inc Stock (PLSE) Latest News

pulisher
Mar 09, 2025

Oppenheimer & Co. Inc. Acquires New Shares in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World

Mar 09, 2025
pulisher
Mar 07, 2025

Pulse Biosciences Schedules Fourth Quarter & Full Year 2024 Financial Results Conference Call for March 27, 2025 - Bluefield Daily Telegraph

Mar 07, 2025
pulisher
Mar 07, 2025

When Will Pulse Biosciences Report Q4 Earnings? Key Date for nsPFA Technology Leader - StockTitan

Mar 07, 2025
pulisher
Mar 06, 2025

Pulse Biosciences, Inc. to Host Earnings Call - ACCESS Newswire

Mar 06, 2025
pulisher
Mar 06, 2025

Pulse Biosciences at TD Cowen Conference: nsPFA Technology Focus By Investing.com - Investing.com Canada

Mar 06, 2025
pulisher
Mar 06, 2025

New York State Common Retirement Fund Sells 3,600 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

(PLSE) Trading Signals - Stock Traders Daily

Mar 05, 2025
pulisher
Mar 04, 2025

Commit To Purchase Pulse Biosciences At $10, Earn 12.9% Annualized Using Options - Nasdaq

Mar 04, 2025
pulisher
Mar 04, 2025

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Joplin Globe

Mar 04, 2025
pulisher
Mar 02, 2025

MONDAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in Pulse Biosciences, Inc. with Losses of $100,000 to Contact the Firm - ACCESS Newswire

Mar 02, 2025
pulisher
Mar 02, 2025

Investor Network: Pulse Biosciences, Inc. to Host Earnings Call - ACCESS Newswire

Mar 02, 2025
pulisher
Feb 27, 2025

Jon Skinner Hired to Manage Pulse Biosciences Finances - MPO-mag

Feb 27, 2025
pulisher
Feb 24, 2025

Pulse Biosciences Releases Nanosecond PFA Catheter Study Results - MPO-mag

Feb 24, 2025
pulisher
Feb 23, 2025

Learn to Evaluate (PLSE) using the Charts - Stock Traders Daily

Feb 23, 2025
pulisher
Feb 23, 2025

Pulse Biosciences (NASDAQ:PLSE) Trading Down 7.8%Here's Why - MarketBeat

Feb 23, 2025
pulisher
Feb 20, 2025

Can Pulse Biosciences' Novel Ablation Technology Disrupt Medical Device Market? Key Presentation Coming - StockTitan

Feb 20, 2025
pulisher
Feb 12, 2025

Where are the Opportunities in (PLSE) - Stock Traders Daily

Feb 12, 2025
pulisher
Feb 10, 2025

Pulse Biosciences (NASDAQ:PLSE) Stock Price Down 6.6%Here's What Happened - MarketBeat

Feb 10, 2025
pulisher
Feb 08, 2025

Pulse Biosciences (NASDAQ:PLSE) Hits New 12-Month HighShould You Buy? - MarketBeat

Feb 08, 2025
pulisher
Feb 06, 2025

Pulse Biosciences Appoints Jon Skinner as Chief Financial Officer - Defense World

Feb 06, 2025
pulisher
Feb 05, 2025

Pulse Biosciences names new CFO, continuing string of C-suite changes - MedTech Dive

Feb 05, 2025
pulisher
Feb 05, 2025

Pulse Biosciences names Jon Skinner as new CFO By Investing.com - Investing.com South Africa

Feb 05, 2025
pulisher
Feb 05, 2025

Pulse Biosciences names Jon Skinner as new CFO - Investing.com India

Feb 05, 2025
pulisher
Feb 04, 2025

Pulse Biosciences, Inc. Appoints Jon Skinner as Chief Financial Officer - BioSpace

Feb 04, 2025
pulisher
Feb 04, 2025

Pulse Biosciences has a new CFO - Mass Device

Feb 04, 2025
pulisher
Feb 04, 2025

Pulse Biosciences Strengthens Leadership with New CFO Appointment - TipRanks

Feb 04, 2025
pulisher
Feb 04, 2025

Pulse Biosciences Names Jon Skinner CFO -February 04, 2025 at 08:54 am EST - Marketscreener.com

Feb 04, 2025
pulisher
Feb 04, 2025

Pulse Biosciences Appoints Jon Skinner As CFO; Stock Up In Pre-market - Nasdaq

Feb 04, 2025
pulisher
Feb 04, 2025

Pulse Biosciences Names Jon Skinner Chief Financial Officer - MarketWatch

Feb 04, 2025
pulisher
Feb 04, 2025

Healthcare M&A Expert Takes CFO Role at Pulse Biosciences with $5B Growth Vision - StockTitan

Feb 04, 2025
pulisher
Feb 03, 2025

Pulse Biosciences (NASDAQ:PLSE) Trading Up 7.6%Time to Buy? - MarketBeat

Feb 03, 2025
pulisher
Feb 01, 2025

Griffin Asset Management Inc. Sells 19,902 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - MarketBeat

Feb 01, 2025
pulisher
Feb 01, 2025

(PLSE) Technical Pivots with Risk Controls - Stock Traders Daily

Feb 01, 2025
pulisher
Jan 30, 2025

Pulse Biosciences’ Nanosecond PFA Technology to Be Featured in Presentations at North American Society for Interventional Thyroidology Annual Meeting - BioSpace

Jan 30, 2025
pulisher
Jan 25, 2025

Pulse Biosciences reports successful AF treatment in study - MSN

Jan 25, 2025
pulisher
Jan 22, 2025

Pulse Biosciences announces presentation of late-breaking data on nsPFA 360-degree cardiac catheter system - Cardiac Rhythm News

Jan 22, 2025
pulisher
Jan 21, 2025

Pulse Biosciences (NASDAQ:PLSE) Shares Up 5.2%Here's What Happened - MarketBeat

Jan 21, 2025
pulisher
Jan 21, 2025

Pulse Biosciences touts positive results from PFA early feasibility study - Yahoo Finance

Jan 21, 2025
pulisher
Jan 21, 2025

Pulse Biosciences Announces Late-Breaking Data from its Nanosecond PFA 360° Cardiac Catheter System First-In-Human Feasibility Study Presented at the AF Symposium - Business Wire

Jan 21, 2025
pulisher
Jan 21, 2025

Pulse Biosciences' Cardiac Catheter Shows 92% Success Rate in Atrial Fibrillation Study - StockTitan

Jan 21, 2025
pulisher
Jan 18, 2025

Barclays PLC Grows Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World

Jan 18, 2025

Pulse Biosciences Inc Stock (PLSE) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Pulse Biosciences Inc Stock (PLSE) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
DUGGAN ROBERT W
Director
Dec 13 '24
Buy
17.18
55,256
949,298
42,328,717
DUGGAN ROBERT W
Director
Dec 12 '24
Buy
17.13
45,404
777,771
42,273,461
DUGGAN ROBERT W
Director
Dec 11 '24
Buy
17.35
56,054
972,344
42,228,057
Barrett Burke Thomas
President and CEO
May 20 '24
Buy
8.56
10,000
85,600
10,000
$160.51
price down icon 2.47%
$15.82
price up icon 0.19%
$60.70
price down icon 0.65%
medical_instruments_supplies COO
$77.73
price down icon 1.69%
medical_instruments_supplies WST
$223.73
price down icon 0.22%
medical_instruments_supplies BAX
$34.55
price up icon 0.41%
Cap:     |  Volume (24h):